Expenses have already been flagged (2.3mil), so this shouldn't really shock the market. Just the cost of getting FDA approval, but it will be nice when CYC can actually bank some of it's high margin business rather than report losses due to FDA costs.
If CYC can get FDA approval and settle its litigation in Germany (expected in the next 12 months) with a nice payout, they should be kicking goals.
Add to My Watchlist
What is My Watchlist?
